Free Trial
TSE:LABS

MediPharm Labs (LABS) Stock Price, News & Analysis

MediPharm Labs logo
C$0.09 0.00 (0.00%)
As of 04/25/2025 03:59 PM Eastern

About MediPharm Labs Stock (TSE:LABS)

Key Stats

Today's Range
C$0.09
C$0.09
50-Day Range
C$0.07
C$0.12
52-Week Range
C$0.06
C$0.12
Volume
288,610 shs
Average Volume
367,758 shs
Market Capitalization
C$37.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.

Receive LABS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter.

LABS Stock News Headlines

MediPharm Labs Corp.
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
XORTX Appoints Michael Bumby As CFO, Replacing James Fairbairn
See More Headlines

LABS Stock Analysis - Frequently Asked Questions

MediPharm Labs' stock was trading at C$0.06 at the beginning of the year. Since then, LABS shares have increased by 50.0% and is now trading at C$0.09.
View the best growth stocks for 2025 here
.

Shares of LABS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that MediPharm Labs investors own include Cronos Group (CRON), Aurora Cannabis (ACB), MediPharm Labs (MEDIF), BlackBerry (BB), HEXO (HEXO), Lightspeed Commerce (LSPD) and Organigram (OGI).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
TSE:LABS
CIK
N/A
Fax
N/A
Employees
130
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-12,047,047.14
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$39.42 million
Cash Flow
C$0.07 per share
Price / Cash Flow
1.30
Book Value
C$0.11 per share
Price / Book
0.82

Miscellaneous

Free Float
N/A
Market Cap
C$37.35 million
Optionable
Not Optionable
Beta
0.88
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (TSE:LABS) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners